Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biotech-beach symbols : SNY save search
Mirador Launches with $400M in Funding, Targets Precision Medicines
Published: 2024-03-21 (Crawled : 15:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
precision
Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Published: 2024-02-28 (Crawled : 19:00) - biospace.com/
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
INBX | $34.46 0.03% 42K
|
Health Technology
|
| O: -0.86%
H: 0.13%
C: -5.66%
year financial results
Endeavor BioMedicines Appoints Enoch Kariuki, Pharm.D. to Board of Directors
Published: 2023-12-19 (Crawled : 14:00) - biospace.com/
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: 0.0%
Impilo Therapeutics Launches to Enable Nucleic Acid-Based Medicines to Effectively Treat Solid Tumor Cancers
Published: 2023-08-15 (Crawled : 17:00) - biospace.com/
LSTA | $2.85 960
|
Manufacturing
|
| O: 0.0%
H: 7.04%
C: 0.0%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -2.02%
H: 0.0%
C: -1.05%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.36%
H: 0.0%
C: 0.0%
treat tumor therapeutics
Recludix Pharma Enters into a Strategic Collaboration with Sanofi to Advance Novel Oral STAT6 Inhibitor in Multiple Immunological and Inflammatory Indications
Published: 2023-07-20 (Crawled : 14:00) - biospace.com/
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.2%
H: 0.7%
C: 0.27%
pharma collaboration sanofi
Appia Bio Expands Leadership Team With Sylvaine Cases, Ph.D. Appointed Chief Business Officer and Alex Babayan, Ph.D. as Vice President, Head of Regulatory Affairs
Published: 2023-06-28 (Crawled : 14:00) - biospace.com/
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: -0.15%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.75%
H: 0.0%
C: 0.0%
business
Escient Pharmaceuticals Announces $120 Million Series C Financing
Published: 2022-11-28 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.57%
H: 1.04%
C: -1.87%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.13%
H: 0.0%
C: 0.0%
pharmaceuticals
Ligand Announces Completion of OmniAb Spin-Off
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 7.74%
H: 0.17%
C: 0.17%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
LGND | $71.255 -1.74% 19K
|
Health Technology
|
| O: 0.0%
H: 1.5%
C: -3.47%
Ligand Announces that Janssen has Received Approval from U.S. FDA for TECVAYLI™ (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Published: 2022-10-26 (Crawled : 12:20) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
AHPA 4 | $6.125 -9.26% 4.33%
|
|
| O: -5.1%
H: 1.72%
C: -8.48%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 2.12%
H: 0.0%
C: 0.0%
LGND | $71.255 -1.74% 19K
|
Health Technology
|
| O: 0.48%
H: 2.13%
C: -0.81%
treatment fda approval
Opiant Pharmaceuticals Announces Notice of Allowance for U.S. Patent with Claims Covering OPNT004 for the Treatment of Cannabinoid Hyperemesis Syndrome
Published: 2022-08-22 (Crawled : 23:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.54%
H: 1.57%
C: 1.57%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: 0.0%
OPNT | $20.65 -0.58% 0.48% 0
|
Health Technology
|
| O: -8.63%
H: 4.42%
C: 2.81%
opnt004 treatment patent
Escient Pharmaceuticals Appoints Joshua Grass, MBA as CEO
Published: 2022-01-05 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 3.68%
H: 0.0%
C: 0.0%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: 0.0%
CERS | News | $1.675 2.13% 200K
|
Health Technology
|
| O: -1.06%
H: 1.23%
C: -4.6%
als ceo
Escient Pharmaceuticals Announces Data Presentations Highlighting the Preclinical and Clinical Development of EP547 at AASLD The Liver Meeting® Digital Experience 2021
Published: 2021-11-04 (Crawled : 13:00) - biospace.com/
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
presentation liver preclinical pre-clinical
Onchilles Pharma Appoints Christopher Twitty, Ph.D., Chief Scientific Officer
Published: 2021-10-26 (Crawled : 14:15) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
pharma
Tentarix Biotherapeutics Emerges with $50 Million Series A
Published: 2021-10-14 (Crawled : 14:00) - biospace.com/
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.2%
H: 0.08%
C: -0.43%
FATE | $4.91 -2.58% 370K
|
Health Technology
|
| O: 1.41%
H: 3.89%
C: 2.48%
iot merge
Neurophth Expands Its Global Gene Therapy Leadership Team with the Appointment of Dr. Zhengbin Li as Head of Commercial
Published: 2021-08-19 (Crawled : 16:00) - biospace.com/
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.44%
H: 0.95%
C: 0.15%
gene therapy therapy gene therapies commercialization
Locanabio Expands Leadership Team with Appointment of Chief Scientific Officer and Chief Medical Officer
Published: 2021-07-06 (Crawled : 14:00) - biospace.com/
RARE F | $43.45 0.16% 67K
|
Health Technology
|
| O: -0.14%
H: 1.39%
C: -2.83%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -1.0%
H: 0.1%
C: -0.25%
SGMO | $0.5225 7.71% 500K
|
Health Technology
|
| O: -0.34%
H: 0.26%
C: -3.6%
BMRN S | $88.95 -1.24% 500K
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: -0.91%
Lengo Therapeutics Appoints Enoch K. Kariuki as Chief Executive Officer
Published: 2021-06-28 (Crawled : 13:00) - biospace.com/
ZNTL | $12.74 1.6% 80K
|
Health Technology
|
| O: 0.1%
H: 2.45%
C: -4.89%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
therapeutics
Join Science 37 for a Panel of Health Industry Leaders Exploring “Decentralized Clinical Trials and the Empowered Patient Trial Experience” at Reuters Webinar
Published: 2021-06-23 (Crawled : 17:00) - biospace.com/
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.59%
H: 0.02%
C: -1.01%
clinical trials trial
GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement
Published: 2021-06-02 (Crawled : 13:15) - biospace.com/
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.42%
H: 0.15%
C: -0.78%
LGND | $71.255 -1.74% 19K
|
Health Technology
|
| O: 0.82%
H: 1.37%
C: -1.0%
biotech iot license
Neurana Pharmaceuticals Appoints Georgia Erbez and Liz Cermak to Board of Directors
Published: 2021-06-01 (Crawled : 13:00) - biospace.com/
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: 0.53%
H: 0.03%
C: -2.72%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.93%
H: 0.09%
C: -0.87%
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
SRFM 4 | $0.6 21.29% 850K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.